About

A seasoned team experienced in developing cancer medicines to create a fully integrated oncology company.

Beyond Conventional Payloads: Unlocking New Therapeutic Landscapes With Precision Degrader-Antibody Conjugates (DACs)

Koichi Ito, PhD Senior Director, Biology and Pharmacology, Prelude Therapeutics Incorporated